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ABSTRACT
The site of action and the distribution of angiotensin II have been studied in the mouse. A
comparison of the ratios of angiotensin 14C and inulin 3H at the time of the pressor effect
reveals an extracellular pattern of distribution . Morphological studies were made using
angiotensin coupled to exogenous enzymes which can be demonstrated histochemically.
Coupling of angiotensin to horseradish peroxidase or cytochrome c, with glutaraldehyde or
difluorodinitrodiphenylsulfone (FNPS) as the coupling agent, does not alter the pattern of
its vasopressor response or that of its inactivation ; nor are differences present between angio-
tensin and the angiotensin-enzyme complexes in the stimulation of in vitro tissue prepara-
tions. Dissociation of the complexes was shown not to occur in vitro, but the possibility of a
serum factor splitting the complexes immediately after intravenous injection cannot be
excluded. Since these complexes are localized on the endothelium and not on the smooth
muscle at the time of maximum hypertension, the endothelium is proposed as the site of
action for angiotensin .
INTRODUCTION
The vasopressor action of angiotensin is rapid in metabolites are found in the first few minutes in
onset and short-lived. The greater part of the both the blood and the urine (8). The speed with
pressor response is thought to be due to a direct which angiotensin II is removed has been inter-
action of the polypeptide on smooth muscle cells preted as indicating tissue binding or uptake
of small arterioles (1) although actions on pe- rather than enzymatic degradation (8, 9) . Thus,
ripheral neuronal stores with release of catechol while the conversion of angiotensin I to II involves
amines (2) and actions on the central nervous an enzymatic action, the initial biological in-
system (3) have been shown .
	
activation of angiotensin II may not be enzymatic .
Angiotensin II results from the enzymatic
	
This paper reports on the localization of
removal of leucine and histidine from the deca- angiotensin II at the onset and the termination of
peptide angiotensin I. This conversion occurs its action on vascular smooth muscle and in organs
largely in the lungs (4) and possibly in the kidney where inactivation has been shown to occur,
(5). On circulation through peripheral vascular using a new technique which allows for the ultra-
beds other than the lung, angiotensin II loses the structural localization of angiotensin .
greater part of its biological activity (6) . Circula-
tion through the lungs removes little if any of this MATERIALS AND METHODS
activity even though bradykinin, another vaso-
active polypeptide, is inactivated on passage Isotope Studies
through this organ (7) . 35S-labeled angiotensin II
	
1-Aspartic-5-isoleucine-angiotensin II-14C with a
is very rapidly cleared from the circulation, and specific activity of 236 mCi/mmole (New England
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419Nuclear Corp ., Boston, Mass.) and methoxy-inulin- 3H
with a specific activity of 128 mCi/g (New England
Nuclear Corp .) as a marker of the extracellular space,
were used. A saline solution of these substances was
prepared so that the specific activity of the inulin- 3H
was five times that of the angiotensin- 14C. Male
Swiss mice weighing 20-30 g each were given intra-
venous doses of angiotensin 10 pg/kg and inulin
100 gg/kg in a volume of 0.25-0.35 ml via the lateral
tail vein. Three groups of five mice each were killed
by decapitation 0.5, 5, and 15 min after the injection .
Samples of the liver, kidney, brain, lung, heart, and
diaphragm averaging 100 mg were digested in I ml of
Nuclear Chicago Solubilizer (N . C. S.), diluted with
0.42 ml of Liquifluor (New England Nuclear Corp .)
and 10 ml of toluene, and counted in a Picker 300
liquid scintillation counter (Picker X-Ray Corp .,
Cleveland, Ohio). 200 µl of plasma were similarly
treated. Quench curves were constructed using
digested liver in N.C.S. as the quenching agent be-
cause this tissue had the greatest amount of pigment .
Enzyme Coupling
To study the localization of angiotensin, synthetic
valyl-5-angiotensin II amide (Hypertensin, Ciba
Limited, Dorval, Quebec, Canada) was coupled to
either horseradish peroxidase (Sigma type II, mol wt
40,000) or cytochrome c (Sigma type VI, mol wt
12,000), using a technique similar to that used for the
coupling of antibodies to enzymes (10) . Angiotensin
was used without removal of the excipients, mannitol
and thimerosal, as they did not interfere with the
reaction. 2.5 mg of angiotensin plus 10 mg of horse-
radish peroxidase or 30 mg of cytochrome c were
dissolved in I ml of 0.1 M phosphate buffer at pH 7 .3.
50 gl of aqueous glutaraldehyde 1 0 / 0 (Ladd Research
Industries, Inc., Burlington, Vt .) were then added to
the angiotensin-peroxidase solution and 100 µl to the
angiotensin-cytochrome c solution . The glutaralde-
hyde was added while the flask containing the enzyme
and the angiotensin was agitated . The mixture was
allowed to react at room temperature for 2 hr with
continuous agitation. After 2 hr the final volume was
increased to 2 ml by the addition of further buffer
and was dialyzed for 48 hr against a total of 12 liters of
0.001 M Tris buffered saline at pH 7.4. Difluorodini-
trodiphenylsulfone (FNPS) was also used as a coupling
agent to make complexes . To couple angiotensin to
enzymes with FNPS, 10 mg of horseradish peroxidase
or 20 mg of cytochrome c were dissolved in 1 ml of
0.5 M carbonate buffer at pH 10 and 200 µl of freshly
prepared 0.57 FNPS in acetone were added. The
reaction was allowed to continue overnight at 4°C and
the reaction mixture was dialysed for 48 hr as above.
Control experiments were done with angiotensin and
enzyme mixed without the addition of the coupling
agents to assure that dialysis would separate the two .
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Following the dialysis the vasopressor activity of the
dialysate and of the angiotensin-enzyme complex was
tested in the rat. To test the completeness of the
separation by dialysis, assay tissues were surrounded
by a dialysis sac in an organ bath and the complexes
were added to the bath solution outside the sac. If
free angiotensin is present outside the sac it will reach
the assay tissue and produce a response because
angiotensin, with a molecular weight of 1000, can
pass freely through the sac.
Glutaraldehyde has been shown to be polymeric
(11) and large complexes might form between the
enzyme and the angiotensin . To determine the ap-
proximate molecular weight of the complexes, samples
were placed on a Sephadex G 100 column 2 .5 X
30 cm with 0 .1 M phosphate buffer at pH 7 .4. The
protein peaks were lyophilized, reconstituted, and
tested for biological activity. Similar studies were done
with the FNPS coupled complexes .
To learn how many molecules of angiotensin were
attached to each molecule of enzyme, a known
amount of angiotensin-14C was added to the angio-
tensin-enzyme solution before the addition of glutaral-
dehyde. A sample of this mixture was then taken for
counting and a similar sample taken following the
coupling reaction. Protein estimations were done
using the Biuret technique (12). The efficiency of the
counting was found by adding an internal standard
of leucine-14C. These experiments were done twice
with both enzymes .
Biological Activity
Several systems were employed to test the bio-
logical activity of the complexes. The rat blood pres-
sure assay was performed using male Sprague-
Dawley rats, weighing 250-300 g, anesthetized with
sodium pentobarbital 30 mg/kg intraperitoneally .
Pressure was measured from a carotid artery and
recorded on a Grass polygraph . All injections were
made intravenously via the jugular or the femoral
vein. In the early experiments every preparation of
the enzyme-angiotensin complex was tested using the
rat blood pressure assay, but after it was found that
the activity was constant, this testing and equating
with known angiotensin concentrations for each
experiment was discontinued . Isolated rabbit aortic
strips in 10 ml baths containing Krebs-Henseleit
solution at 37°C, through which bubbled a mixture
of 95% 02 and 5% C02, were also used ; contractile
responses to angiotensin were isotonically recorded
on a smoked drum after a 2 hr relaxation period (13) .
Ten different sets of complexes of both enzymes were
tested on a total of 20 aortic strips . In ten experiments
on aortic strips, the bath solution was replaced with
mineral oil at 37°C to study the inactivation of the
complexes and of angiotensin by angiotensinases (14) .
Three other sets of complexes were tested in threeTABLE I
DPM Ratios of Angiotensin- 14C to Inulin- 3H in Mouse
groups of perfused and superfused organs. To test the
degree of inactivation by tissues, rabbit lungs and
kidneys were perfused with Krebs-Henseleit solution
and the angiotensin activity was measured by super-
fusing an isolated rat ascending colon with the per-
fusate (15) .
Histochemistry
To localize the angiotensin-enzyme complex, male
Swiss mice weighing 20-30 g were injected with the
complex in a volume not greater than 0.6 ml, so that
they received 2-5 mg of horseradish peroxidase or
10-15 ing of cytochrome c and a pressor dose equiva-
lent to 2-20 pg/kg of angiotensin. After the injection,
the mice were killed by decapitation at intervals of
0-1, 2, and 5 min. Two mice for each of the enzymes
were used at each interval, giving a total of 12 mice .
Samples from the kidney, liver, lung, diaphragm,
adrenal and choroid plexus were fixed in 3% 0 .1 M
phosphate-buffered glutaraldehyde at pH 7.3 for 3 hr
and then washed overnight in the same buffer .
Sections of the fixed tissues were cut at 50 µ on a
Smith-Farquhar microtome and the sections were
placed in a Tris-buffer solution of 3,3'-diamino-
benzidine (Sigma Chemical Co., St. Louis, Mo.) for a
20 min preincubation before being placed in the final
reaction medium of 3,3'-diaminobenzidine and
hydrogen peroxide according to the method of
Graham and Karnovsky (16). Following the reaction
the tissues were postfixed in 2% osmium tetroxide for
1 hr, then dehydrated in alcohol and embedded in
Epon. A similar procedure was used for the cyto-
chrome c except that the tissues were incubated in a
citrate buffer at pH 3 .9 according to the method of
Karnovsky and Rice (17). Tissues used in the in vitro
system either were fixed and treated as above for
electron microscopy or were frozen, sectioned and
then fixed, and the histochemical reactions were
carried out on the slide. Sections of the embedded
Mean values with standard errors of the mean . Comparisons were made between 0.5
and 5 min, and between 0 .5 and 15 min, using Student's t test.
* P < 0.01 .
$ P < 0.05.
material were cut with a Dupont diamond knife and
examined in a Philips EM 300 microscope, first in an
unstained condition and then, if the reaction was
adequate, the sections were stained with lead citrate
and uranyl acetate and reexamined.
RESULTS
Isotope Studies
The ratios of angiotensin to inulin as deduced
from their DPMs are shown in Table I . In the
early interval, up until 1 min after the injection,
the ratios for all tissues are 1 : 1 . The liver then
accumulates more angiotensin, or its metabolites,
than inulin so that at 5 min the ratio is 25 .2 f
4.05 and at 15 min it is 27.9 f 7.53, whereas in
most other tissues it is still around I . At 5 min the
brain has increased its ratio from 0.9 f 0.15 to
2.3 f 0.5 (p < 0.05) and at 15 min the ratio
reaches 3 .6 f 0.65 (p < 0.01). At 15 min, ratios
for the kidney and the lung are significantly
lowered and the low ratio persists for the lung at
15 min.
Enzyme Coupling and Biological Activity
A typical assay of the activity of the enzyme-
angiotensin complexes is seen in Fig . 1 where two
different amounts of horseradish peroxidase have
been coupled to the same amount of angiotensin .
The ratio of angiotensin and the enzyme in the
complexes could be altered by changing the pro-
portions of the two constituents before the addition
of glutaraldehyde . Thus, a balance could be
achieved where there was sufficient enzyme to be
histochemically demonstrable and the dose of
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Tissue 0-0.5 min 5 min 15 min
Liver 1 .1 f 0 .08 25 .2 f 4 .05* 27 .9 f 7 .53*
Brain 0 .9 f 0 .15 2 .3 f 0 .5$ 3 .6 f 0 .65*
Kidney 1 .1 f 0 .19 0 .4 f 0 .081 0.8 f 0.13
Lung 1 .0 f 0 .13 0 .4 f 0 .04* 0.6 f 0.11*
Heart 0 .9 f 0 .19 0 .9 f 0 .18 1 .7 f 0 .45
Diaphragm 1 .0 f 0 .03 0 .8 f 0 .06 1 .1 f 0.25
Serum 0 .6 f 0 .00 0 .2 f 0 .00 0 .2 f 0 .00FIGURE 1 Blood pressure recording of a rat . DI and D2 signify the injection of 0 .25 ml of the first and
second dialysate. HRP-A 1 indicates an injection of 0 .25 ml of an enzyme-angiotensin complex made from
10 mg of horseradish peroxidase and 2 .5 mg of angiotensin, and HRP-A 2 indicates one made from 15 mg
of enzyme and 2 .5 mg of angiotensin. Angiotensin (ANGIO) of known amount and a volume of 0 .25 ml .
SAL is an injection of 0.25 ml of saline .
angiotensin could be kept low . The onset in the
elevation of the blood pressure and the duration
of the response produced by the complexes are
identical to those obtained with angiotensin alone .
The FNPS coupled complexes were nearly as
active as those produced by glutaraldehyde . In
the experiments in which no coupling agent was
added to the mixture of angiotensin and enzyme,
the contents of the dialysis sac after dialysis had no
biological activity . Fig. 2 shows the absence of
free angiotensin in the complexes following dialysis
for 48 hr.
The cytochrome c-angiotensin complexes
coupled with glutaraldehyde came off the Sepha-
dex column as a single peak partially with the void
volume. The FNPS coupled angiotensin-cyto-
chrome c complexes came off as a peak in a position
similar to ribonuclease (mol wt 13,700) . The
angiotensin-horseradish peroxidase complexes
made with either glutaraldehyde or FNPS came
off the column in a position behind bovine albumin
(mol wt 69,000) . The complexes retained their
biological activity after lyophilization .
Results typical of the aortic strip assay are
shown in Fig . 3 . Equipotent amounts of angio-
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tensin and cytochrome c-angiotensin complex
produce responses characterized by a similar onset
of action. The aortic strip contracted by free
angiotensin relaxes rapidly when the bath is
washed out or the bath solution is substituted by
oil. Such a relaxation is not seen when the aortic
strip is contracted by either of the angiotensin-
enzyme complexes and oil is substituted for the
bath solution . If, after being in oil for 15 min the
strips are washed, they relax slowly but if left in
oil for 1 hr or more they do not relax when they
are washed .
The perfused rabbit lungs and kidneys and the
superfused rat ascending colon experiments show
no detectable differences in the pattern of response
to angiotensin and the angiotensin-enzyme com-
plexes when equipotent doses are used . The kidneys
remove about 50% of the biological activity of
both angiotensin and the angiotensin-enzyme
complexes and no detectable loss of activity
occurs when either angiotensin or the complexes
are perfused through the lungs (Fig . 4) .
The results of the addition of angiotensin- 11C
to the angiotensin-enzyme-glutaraldehyde com-
plexes show that, for each molecule of horseradishI'
A
	
i
CYTO-A
OUTSIDE
1
3 gm
A
CYTO-A
INSIDE
ANGIO OUTSIDE
5 min
FIGURE 2 Contractions of a portion of rat ascending
colon in a 40 ml organ bath . The assay tissue is sur-
rounded by a dialysis sac . The upper tracing shows the
effect of 1 ml of cytochrome-angiotensin complex
(CYTO-A), made with FNPS, equipotent to 1 ml of
10--l g/ml of angiotensin added to the bath outside the
sac and later when 0 .5 ml is added inside the sac . The
lower tracing shows the effects of 1 ml of 10 --6 g/ml of
angiotensin (ANGIO) added outside .
oil
60 min
I
ANGIOTENSIN 100ng
oil
wash
CYTO-A
oil	-. 30
min
	
wash
FIGURE 3 Kymograph tracings of rabbit aortic strips
contracted by angiotensin, cytochrome c-angiotensin
complex (CYTO-A), and horseradish peroxidase-angio-
tensin complex (HRP-A) . The bath solution was
changed to oil where indicated (oil) .
peroxidase, there are one to two molecules of
angiotensin and one molecule of angiotensin for
each molecule of cytochrome c with some
chrome not coupled with angiotensin .
Histochemistry
AORTA : The histochemical studies
cyto-
on the
aortic strips exposed to the angiotensin-enzyme
complexes show the reaction product at the
periphery of the tissue. The reaction product is
present in the endothelial region, in scattered
areas at the margins, and in a few macrophages
in the adventitia. Electron microscope studies of
the aortic strips show the reaction product in small
vesicles in the endothelial cells as well as adhering
to the cell surface. Loose collections of the reaction
product are also found in the subendothelial area
in those strips left in oil for 1 hr or longer . In some
areas where the structure of the strip shows disrup-
tion due to the dissection of the strip, no endo-
thelium is seen but collections of the reaction
product are seen within the ground substance and
adhering to the elastica (Fig. 5). No reaction
product is seen in any of the smooth muscle cells
of the aorta, and in only a few areas is the reaction
product seen in contact with the smooth muscle
cell surfaces at the margin of the strips .
The histochemical findings of the in vivo
studies are given for each of the organs or tissues
examined over the 5 min interval .
KIDNEY : In the 2 min interval after the
injection of either of the enzyme-angiotensin
complexes, reaction product is prominent in the
glomeruli where it passes through with no diffi-
FIGURE 4 Tracings showing the contraction of the
superfused rat ascending colon . Addition of angiotensin
(ANGIO) or either of the two enzyme-angiotensin com-
plexes to the superfusate is indicated by B . Passage of
angiotensin or the enzyme complexes through the kid-
ney is indicated by K, and through the lung by L .
CYTO-A, cytochrome c-angiotensin complex ; HRP-A,
horseradish peroxidase-angiotensin complex .
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423FIGURE 5 5a, A frozen section of an aortic strip contracted by cytochrome c-angiotensin complex with
the histochemical reaction performed on the slide. Reaction product only on endothelium . X 250. 5b, An
aortic strip contracted by angiotensin and treated similarly to that of 5a. No reaction product is seen .
X 250. 5c, An electron micrograph of an aortic strip contracted by cytochrome c-angiotensin complex.
Reaction product is seen beneath the endothelium and on the endothelial surface . X 14,000. 5d, a dif-
ferent area of the same strip showing reaction product adhering to elastic tissue. X 11,000.
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reaction product is clearly seen in the tubules,
both adhering to the microvilli and within small
vesicles. A marked interstitial deposition of the
product is also seen and there is extensive permea-
tion of the basal infoldings of many of the tubule
cells (Fig. 6) .
LIVER : Large quantities of the reaction
product are found in the liver as early as 1 min
after the injection of the complexes . The localiza-
tion of this product is in vesicles of the sinusoidal
lining cells and within the space of Disse. No intra-
cellular reaction product is found in the hepato-
cytes up to 5 min after the injection.
ADRENALS : As early as 30 sec, both enzyme
complexes penetrate into the interstitial spaces of
the adrenal cortex (Fig. 7). The reaction product
is still present 5 min after the injection and appears
in small spaces between adjacent cells .
DIAPHRAGM : In the half-minute interval
after the injection of the complexes there is no
visible reaction product at the basal lamina of the
basal lamina of the blood vessels (Fig. 8), but at
5 min after the injection there is abundant reaction
product in the extracellular space (Fig. 9). Many
of the blood vessels show the reaction product in
endothelial vesicles both at the early intervals
and later.
CHOROID PLEXUS : Vesicles containing the
reaction product are seen in the cells of the
choroid plexus 5 min after the injection, and some
of these vesicles are seen near the villous border
but none are seen to be emptyine into the ventric-
ular side. The reaction product is also seen in the
extracellular space surrounding the blood vessels.
L U N G S : In the interval up to 5 min after the
injection, the reaction product is seen in the
vessels. There is also some uptake into the endo-
thelial vesicles and passage through the endo-
thelial, but not the epithelial, junctions .
DISCUSSION
Intravenous inulin rapidly moves from the plasma
into the extracellular space where it reaches a peak
concentration 5-10 min after the injection (18),
and it has been shown to be extracellular in such
tissues as the cat cervical ganglion 2 min after an
injection (19). If a substance has a 1 :1 ratio to
inulin, it may be interpreted as meaning that it
has a tissue distribution similar to that of inulin .
The reduction of the ratio in the kidney at 5 min
is most likely due to the high clearance of inulin
in relation to the amount of angiotensin present .
The statistically significant low ratios in the lung
at 5-15 min are consistent with the known in-
ability of the lung to remove angiotensin on pas-
sage through its vascular bed .
From these isotope studies several conclusions
can be made. In the early stages of its action,
when the pressor effect is maximal and at the time
period when it is being inactivated or removed
from the circulation, angiotensin is extracellular
and at the cell surface . This indicates that the site
of the pressor action at least, and of the inactivation
or removal of angiotensin, is at the plasma mem-
brane of either the endothelial or the smooth
muscle cells. Since inulin has not been shown to
pass into the extracellular space of the brain at
this early stage, our findings for the I min interval
indicate that angiotensin is still outside the blood
brain barrier but, at a later time, it does gain
access to the brain substance. The gradual in-
crease in the ratio may indicate passage either by
way of the blood vessels or by the choroid plexus .
The angiotensin-enzyme complexes have been
shown to be strongly linked by glutaraldehyde and
FNPS, and that, at the most, two molecules of
angiotensin are coupled to each molecule of
enzyme. The coupling procedures reduce the
vasopressor response to angiotensin but do not
alter the pattern of this response in terms of
either time of onset or duration of action . The rate
of inactivation of the complex by perfusion through
the kidney and the lung is identical to that of
angiotensin alone.
The substitution of oil for the aqueous phase of
an organ bath removes all of the pharmacological
substance from the bath except that amount which
is in, or on, the assay tissue and prevents this latter
amount from leaving the tissue (14). If the tissue
can inactivate the pharmacological substance by
metabolic means, or if the substance can diffuse
into the tissue and thus leave the site of its action,
it will cease to stimulate the tissue (14). This has
been illustrated by the action of noradrenaline on
aortic strips. If a strip is first contracted by nor-
adrenaline in an aqueous bath and the aqueous
solution is then replaced with oil, the contracted
strip will relax because the noradrenaline is either
metabolized or diffuses away from its site of action .
The situation is similar for angiotensin . An- aortic
strip contracted by the action of angiotensin will
relax when the aqueous solution is replaced by oil
(14), because free angiotensin can diffuse into the
RICHARDSON AND BEAULNES The Cellular Site of Action of Angiotensin 425FIGURE 6 Kidney cortex 30 sec after an injection of HRP-A complex . Reaction product is seen in the
interstitium (1) and within the basal infoldings (2). X 17,160 .
42 6FIGURE 7 Adrenal cortex 30 sec after an injection of HRP-A complex . There is reaction product in the
interstitium and just starting to penetrate between the cells (arrow) . X 12,000 .
427Fiutma 8 A capillary in the diaphragm 30 sec after an injection of HRP-A complex . The reaction
product is present in the lumen, within luminal endothelial vesicles (1), and just starting to penetrate
the endothelial junction (2) . A similar distribution is found in arterioles and arteries. X 27,000 .
428FIGURE 9 A capillary in the diaphragm 5 min after an injection of HRP-A complex. There is reaction
product in the lumen, in endothelial vesicles, and in the interstitium (arrow) . X 24,000 .
429tissue. The interpretation of the sustained contrac-
tion found when the aortic strips are stimulated
by the angiotensin-enzyme complexes and the
aqueous solution is replaced by oil is as follows :
the complexes are too large to diffuse into the
tissue and thus they remain at their site of action
and continue to stimulate. If free angiotensin was
present, or if the tissue was dissociating the com-
plexes and producing free angiotensin, the strips
would be expected to relax as the free angiotensin
was either metabolized or diffused away from its
site of action. The sustained contraction of the
aortic strip contracted by the angiotensin-enzyme
complexes demonstrates that free angiotensin is
not present, nor is it produced by an action of the
tissue on the complexes .
The aortic strip experiments, in conjunction
with the experiments in which the assay tissue was
protected by a dialysis sac, show that free angio-
tensin is neither present in the complexes nor
produced by the tissue acting on the complexes .
It is possible, however, that upon intravenous
injection of the complexes a serum factor splits
the complex and the vasopressor response seen is
due to free angiotensin. If this was the case, com-
plete dissociation would have to occur within 5
sec after the intravenous injection, since this is the
average period, including circulation through the
lungs, between injection and initiation of the
vasopressor response . The dissociation must be
complete because equipressor amounts of the
complexes are also equal in the stimulation of in
vitro assay systems, and dissociation can be shown
not to occur in these systems . Furthermore, no
difference in the onset or in the pattern of the
vasopressor response between the complexes and
angiotensin was found . A difference would be
expected if the complexes had to be dissociated
before they could act. From these considerations,
dissociation of the complexes is thought to be
unlikely.
The distribution of horseradish peroxidase after
an intravenous injection has been studied in the
mouse (16, 20-25) . These studies have been done
at varying intervals and have included nearly all
organs. Karnovsky has shown that the endothelial
junctions of the continuous type endothelium most
likely represent the small pore system which has
been proposed from physiological studies (20) .
This system applies to lipid insoluble substances
with a low molecular weight and a radius less than
40-45 A. Horseradish peroxidase has a radius of
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25 A, its molecular weight is 40,000, and it would
be expected to just fit a pore system (20). In
vessels where there are zonulae occludentes such
as in the brain, no passage of the enzyme is seen
between the endothelial cells (24). In Karnovsky's
studies on cardiac and skeletal muscle the capil-
aries showed the histochemical reaction product
of horseradish peroxidase in the lumen of the
vessels, in endothelial vesicles, and at the beginning
of the intercellular junctions, 1-5 min after the
injection of the peroxidase (20) . After 5 min there
was reaction product at the basal lamina, and some
penetration into the T system (20) . In skeletal
muscle the penetration to the basal lamina was
thought to be slower than in the cardiac muscle
capillaries (20) . Although, in theory, transport
across the endothelium of a marker such as
horseradish peroxidase could occur in less than
1 sec, this has not been morphologically demon-
strated (26, 27) . Retention of injected proteins such
as horseradish peroxidase does not occur in organs
which have fenestrated capillaries. In these organs
there is a rapid passage of the enzyme into the
extracellular space . In the adrenal and the kidney
the reaction product is seen throughout the extra-
cellular space 30 sec after the injection . In the
pancreatic islets there is an accumulation 40 sec
after an injection (22), and a similar rapid accu-
mulation is seen in the intestine (25) .
The angiotensin-enzyme complexes of both
horseradish peroxidase and cytochrome c were
found to have a distribution like that of the pure
horseradish peroxidase at the times studied and
there did not appear to be any alteration in the
vessel permeability to the complexes, although
elevations in blood pressure do produce changes in
vascular permeability (28) . The similarity in
distribution of the cytochrome c and the horse-
radish peroxidase complexes is likely due to the
large molecular weight of the former produced by
polymerization with glutaraldehyde .
The detailed anatomy of the microvasculature,
small arterioles, precapillary sphincters, arteriole
capillaries, and venules has been recently described
using a new technique which permits the examina-
tion of the vessels in longitudinal section before
selection of smaller sites for detailed examination
(29, 30) . It was possible to demonstrate the de-
tailed anatomy of these vessels at points where their
gross structure changes. Several findings of these
studies are relevant to this discussion. The small
arterioles (less than 50 µ) and the precapillaryvesicles
basemen-t
membrane
smooth musc e
endothelium
m oe'ndothelial
junctions
FIGURE 10 Schematic representation of the endothelium and the myoendothelial junctions as described
by Rhodin (29, 30) . The sites of passage of the enzyme-angiotensin complexes are the maculae occludentes
and the vesicles of the endothelium .
sphincters are shown to have numerous myo-
endothelial connections (Fig. 10) of a tight junc-
tion type (29). Similar connections also exist
between endothelial cells and pericytes (31), as
well as in larger arterioles and arteries where they
penetrate the elastic interna (32). Rhodin (29)
has suggested that the endothelial cells act as
receptors for humoral substances. He suggests
that they may allow these substances to pass
through to the smooth muscle cells or may transmit
some signal by means of the myoendothelial con-
nections to the smooth muscle cell . Capillary
endothelium has also been shown to be the site of
action for other vasoactive substances where
endothelial contraction has been demonstrated
(33).
The localization of the angiotensin-enzyme
complexes on the endothelium and not on the
smooth muscle during the vasopressor response is
compatible with the hypothesis that receptor sites
are localized on the surface of endothelial cells .
This hypothesis is also supported by the observa-
tion that aortic strips contract when exposed to
the angiotensin-enzyme complexes in vitro and
that the histochemical reaction product of these
complexes is found in the region of the endothelium
and not on the smooth muscle cells.
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